ストックスクリーナーアプリを入手
264.69
1.73%
-4.67
アフターアワーズ：
264.69
前日終値:
$269.36
開ける：
$268.15
24時間の取引高:
1.61M
Relative Volume:
0.93
時価総額：
$51.50B
収益：
$328.68B
当期純損益:
$2.55B
株価収益率:
20.31
EPS:
13.0349
ネットキャッシュフロー:
$1.56B
1週間 パフォーマンス:
-3.72%
1か月 パフォーマンス:
-12.93%
6か月 パフォーマンス:
-26.50%
1年 パフォーマンス:
-9.12%
1日の値動き範囲:
$262.67
$269.36
1週間の範囲:
$262.67
$274.92
52週間の値動き範囲:
$244.82
$377.54
Cencora Inc Stock (COR) Company Profile
Compare COR vs MCK, CAH, HSIC, AHG
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
264.69 | 52.41B | 328.68B | 2.55B | 1.56B | 13.03 |
MCK
Mckesson Corp
|
734.82 | 89.24B | 403.43B | 5.10B | 5.41B | 38.47 |
CAH
Cardinal Health Inc
|
195.15 | 46.09B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
76.40 | 8.72B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
1.49 | 1.30B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-29 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2026-01-22 | アップグレード | Jefferies | Hold → Buy |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-06-03 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | 再開されました | Mizuho | Outperform |
| 2024-09-18 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2024-01-03 | 開始されました | Barclays | Overweight |
| 2023-12-14 | 開始されました | Wells Fargo | Equal Weight |
| 2023-03-31 | 開始されました | Citigroup | Buy |
| 2023-01-31 | 再開されました | Evercore ISI | Outperform |
| 2022-10-11 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-08-22 | 再開されました | Morgan Stanley | Equal-Weight |
| 2022-07-11 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-06-07 | アップグレード | Deutsche Bank | Hold → Buy |
| 2022-05-26 | アップグレード | Barclays | Equal Weight → Overweight |
| 2022-04-12 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2021-03-12 | 再開されました | Evercore ISI | In-line |
| 2021-02-04 | アップグレード | Evercore ISI | In-line → Outperform |
| 2021-02-02 | アップグレード | Cowen | Market Perform → Outperform |
| 2021-01-06 | アップグレード | BofA Securities | Underperform → Neutral |
| 2021-01-06 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | 開始されました | Mizuho | Neutral |
| 2020-08-06 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | 開始されました | Barclays | Underweight |
| 2020-06-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | 再開されました | Credit Suisse | Outperform |
| 2020-04-16 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-03-17 | アップグレード | Citigroup | Neutral → Buy |
| 2020-02-11 | ダウングレード | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | 開始されました | Deutsche Bank | Hold |
| 2019-07-10 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | 開始されました | Guggenheim | Buy |
| 2019-04-10 | ダウングレード | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-02-11 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2019-01-17 | 開始されました | UBS | Buy |
| 2018-12-10 | ダウングレード | Jefferies | Buy → Hold |
| 2018-10-26 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | 開始されました | Berenberg | Buy |
| 2018-07-17 | 再開されました | Stifel | Hold |
| 2018-04-09 | 開始されました | MoffettNathanson | Buy |
| 2018-03-12 | アップグレード | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | 開始されました | JP Morgan | Neutral |
| 2017-09-22 | 開始されました | William Blair | Outperform |
すべてを表示
Cencora Inc (COR) 最新ニュース
Is Cencora’s New CFO, $2 Billion Buyback, and Lawsuit Trio Altering The Investment Case For Cencora (COR)? - Yahoo Finance
Cencora, Inc. (COR) Stock Analysis: Evaluating a 32% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Cencora Inc. stock (US15135B1017): steady trading as NYSE healthcare distributor holds fiscal 2026 E - AD HOC NEWS
Insider Spends US$1.1m Buying More Shares In Cencora - simplywall.st
Cencora Appoints Eva Boratto as CFO and Reaffirms 2026 Financial Guidance - Minichart
Cencora Inc. stock (US15135B1017): new CFO appointment and 2026 EPS guidance reaffirmed - AD HOC NEWS
Assessing Cencora (COR) Valuation After Recent Share Price Weakness And Long Term Gains - simplywall.st
Cencora, Inc. (COR) Appoints New CFO and Reaffirms Financial Gui - GuruFocus
Eva C. Boratto named Cencora Executive VP & CFO as James F. Cleary to retire - TradingView
Cencora (NYSE: COR) hires new CFO Eva Boratto and reaffirms 2026 and long-term EPS targets - Stock Titan
Cencora appoints Eva Boratto as CFO, reaffirms guidance - MSN
Insider Buying: Dermot Durcan Acquires Shares of Cencora Inc (CO - GuruFocus
Cencora director D. Mark Durcan buys $1.07m in stock By Investing.com - Investing.com India
Cencora director D. Mark Durcan buys $1.07m in stock - Investing.com
Cencora Insider Bought Shares Worth $1,065,040, According to a Recent SEC Filing - marketscreener.com
Director Dermot Durcan adds 4,000 Cencora (NYSE: COR) shares - Stock Titan
Cencora Inc. stock (US15135B1017): shares react to investor investigations after guidance reaffirmat - AD HOC NEWS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc.COR - PR Newswire
Cencora, Inc. Announce CFO Changes - marketscreener.com
Cencora, Inc. Announces Executive Changes - marketscreener.com
Deals tracker: HCA to acquire Texas college - Modern Healthcare
Cencora Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Is Cencora (COR) Starting To Look Attractive After Recent Healthcare Distribution Headlines? - simplywall.st
Cencora (COR) Reaffirms FY26 Adjusted EPS Guidance - GuruFocus
Cencora hits 52-week low after guidance cut - MSN
CAH vs. COR: Which Healthcare Distributor Stock Is the Better Buy? - TradingView
Cencora names Eva Boratto as CFO, reaffirms fiscal 2026 guidance By Investing.com - Investing.com Australia
Cencora names Eva Boratto as CFO, reaffirms fiscal 2026 guidance - Investing.com
Cencora nabs ex-CVS exec as new CFO - Yahoo Finance
Ex-Bath & Body Works CFO tapped to guide Cencora’s 2026 earnings - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Cencora, Inc. (COR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Cencora Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Cencora, Inc. (COR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Cencora, Inc. (COR) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Cencora, Inc. (COR) Stock Analysis: Healthcare Giant With A 29.80% Upside Potential - DirectorsTalk Interviews
If You Invested $100 In Cencora Stock 10 Years Ago, You Would Have This Much Today - Sahm
Cencora Inc. stock (US15135B1017): new leadership move as former CEO returns as chair amid healthcar - AD HOC NEWS
Cencora raises earnings outlook on share repurchases - MSN
BlackRock Mid-Cap Growth Equity Portfolio's Cencora Inc(COR) Holding History - GuruFocus
Cencora Inc (COR) Stock Up 3.6% and Still Undervalued -- GF Scor - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Is Investigating Cencora, Inc. (COR) And Encourages Investors to Connect - ACCESS Newswire
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora Inc. stock (US15135B1017): guidance tweak and extra $2 billion buyback attract fresh attenti - AD HOC NEWS
Cencora: Board of Directors Authorized New Shr Repurchase Program to Purchase Up to Additional $2.0B of Stk >COR - Moomoo
Cencora Raises Fiscal 2026 EPS Outlook, Authorizes $2 Billion Share Buyback - Moomoo
Cencora revises forecast for 2026, approves $2 billion share buyback - marketscreener.com
$2 billion stock buyback: Cencora lifts 2026 earnings forecast - Stock Titan
Cencora Announces Updated Fiscal Year 2026 Financial Outlook - marketscreener.com
Cencora, Inc. announces an Equity Buyback for $2,000 million worth of its shares. - marketscreener.com
Cencora stock (US15135B1017): transformation story after name change and solid earnings - AD HOC NEWS
Cencora Inc (COR) 財務データ
収益
当期純利益
現金流量
EPS
0.84%
大文字化:
|
ボリューム (24 時間):